Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukemia:a randomized,open-label,phase 3 trial .Activity and tolerability of the bruton ’ s tyrosine kinase(BTK)Inhibitor PCI-32765 in patients with chronic lym ......